SPONSOR
The Netherlands Cancer Institute
Total Trials
10
Recruiting
10
Phases
Phase 2, Phase 1, Phase 2, Phase 3, Phase 1, Phase 2
Conditions studied: Penile CancerMelanomaOral CancerMetastatic Squamous Cell Carcinoma of the VulvaProstate CancerCervical CancerBladder CancerLung CancerHead and Neck CancerMetastatic Microsatellite-stable Colorectal Cancer
The Netherlands Cancer Institute is a clinical research sponsor with 10 registered studies on ClinicalTrials.gov, of which 10 are actively recruiting participants. Research covers conditions including Penile Cancer, Melanoma, Oral Cancer, Metastatic Squamous Cell Carcinoma of the Vulva.
The trial portfolio spans Phase 2, Phase 1, Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — The Netherlands Cancer Institute
How many clinical trials has The Netherlands Cancer Institute sponsored?
ClinicalMetric currently tracks 10 clinical trials sponsored by The Netherlands Cancer Institute, of which 10 are actively recruiting participants. These trials cover conditions including Penile Cancer, Melanoma, Oral Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does The Netherlands Cancer Institute research focus on?
The Netherlands Cancer Institute clinical trials span Penile Cancer, Melanoma, Oral Cancer, Metastatic Squamous Cell Carcinoma of the Vulva, Prostate Cancer, and additional conditions. The research pipeline includes Phase 2, Phase 1, Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a The Netherlands Cancer Institute clinical trial?
To participate in a The Netherlands Cancer Institute trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all The Netherlands Cancer Institute trials with current recruitment status updated daily.
Clinical Trials by The Netherlands Cancer Institute
NCT06666634
Recruiting
Validation of ICG-99mTc-nanoscan as Hybrid Tracer for Sentinel Node Biopsy
Penile Cancer
NCT04161664 Phase 2
Recruiting
Treatment of Metastatic Vulvar Carcinoma With Carboplatin and Paclitaxel Chemotherapy
Metastatic Squamous Cell Carcinoma of the Vulva
NCT06691776
Recruiting
Feasibility of CBCT-Guided Online Adaptive Radiotherapy (FASCINATE)
Prostate Cancer
NCT06012734 Phase 1
Recruiting
LB-100 (PP2A Inhibitor) and Atezolizumab (PD-L1 Inhibitor) in Metastatic Colorectal Cancer Patients
Metastatic Microsatellite-stable Colorectal Cancer
NCT02910895
Recruiting
A Platform of Patient Derived Xenografts (PDX) and 2D/3D Cell Cultures of Soft Tissue Sarcomas (STS)
Soft Tissue Sarcoma
NCT07310758 Phase 2, Phase 3
Recruiting
Contrast-enhanced Ultrasound for Sentinel Node Detection
Melanoma
NCT05700656 Phase 1, Phase 2
Recruiting
Galunisertib Combined With Capecitabine in Advanced CRC With PM
Colorectal Cancer Metastatic
NCT04351204
Recruiting
The MR-Linac Technical Feasibility Protocol
Tumors at All Sites Which Will Receive Radiotherapy
NCT06855095 Phase 2, Phase 3
Recruiting
Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting Somatostatin Analogues - ATSA Trial
Neuroendocrine Tumors
NCT03819829
Recruiting
Blood Sampling of Healthy Volunteers for Immunological Research
Healthy Volunteers
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology